Intravenous Immunoglobulin Reduces Risk of Severe Infection When Used with BCMA Bispecific Antibody for Multiple Myeloma

Source: Pharmacy Times articles

Intravenous immunoglobulin could potentially be given throughout the duration of anti-BCMA bispecific antibody therapy for the treatment of multiple myeloma.
Read More